These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 458305

  • 1. Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings].
    Delitala G, Stubbs WA, Yeo T, Jones A, Thorner MO, Besser GM.
    J Endocrinol; 1979 May; 81(2):121P. PubMed ID: 458305
    [No Abstract] [Full Text] [Related]

  • 2. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.
    MacLeod RM, Lehmeyer JE.
    Endocrinology; 1974 Apr; 94(4):1077-85. PubMed ID: 4818768
    [No Abstract] [Full Text] [Related]

  • 3. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    Strickland JR, Cross DL, Birrenkott GP, Grimes LW.
    Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
    Pasteels JL, Danguy A, Frérotte M, Ectors F.
    Ann Endocrinol (Paris); 1971 May; 32(1):188-92. PubMed ID: 5556257
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R.
    Adv Neurol; 1982 May; 33():325-34. PubMed ID: 7055013
    [No Abstract] [Full Text] [Related]

  • 15. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    Sibley DR, Creese I.
    Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
    [Abstract] [Full Text] [Related]

  • 16. Direct inhibition by ergocornine of pituitary prolactin release.
    Lu KH, Koch Y, Meites J.
    Endocrinology; 1971 Jul; 89(1):229-33. PubMed ID: 5089657
    [No Abstract] [Full Text] [Related]

  • 17. Dopaminergic modulation of nNOS expression in the pituitary gland of male rat.
    Carretero J, Weruaga E, Hernández E, Burks D, Riesco JM, Rubio M, Briñón JG, Aijón J, Vázquez R, Alonso JR.
    Anat Embryol (Berl); 2003 Dec; 207(4-5):381-8. PubMed ID: 14618399
    [Abstract] [Full Text] [Related]

  • 18. [The mode of action of ergocornin on the secretion of prolactin].
    Pasteels JL, Ectors F.
    Arch Int Pharmacodyn Ther; 1970 Jul; 186(1):195-6. PubMed ID: 5473176
    [No Abstract] [Full Text] [Related]

  • 19. The biphasic regulation of prolactin secretion by dopamine agonist-antagonists.
    MacLeod RM, Lamberts SW.
    Endocrinology; 1978 Jul; 103(1):200-3. PubMed ID: 744072
    [Abstract] [Full Text] [Related]

  • 20. Neuropharmacological intervention on the pituitary-hypothalamic relationship.
    Tuomisto J.
    Ann Clin Res; 1978 Jul; 10(3):120-32. PubMed ID: 31130
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.